Shawn Singh - Net Worth and Insider Trading
Shawn Singh Net Worth
The estimated net worth of Shawn Singh is at least $76,203 dollars as of 2024-11-13. Shawn Singh is the CHIEF EXECUTIVE OFFICER of Vistagen Therapeutics Inc and owns about 26,008 shares of Vistagen Therapeutics Inc (VTGN) stock worth over $76,203. Details can be seen in Shawn Singh's Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that Shawn Singh has not made any transactions after 2022-08-17 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.
Transaction Summary of Shawn Singh
Shawn Singh Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, Shawn Singh owns 2 companies in total, including Vistagen Therapeutics Inc (VTGN) , and Echo Therapeutics Inc (ECTE) .
Click here to see the complete history of Shawn Singh’s form 4 insider trades.
Insider Ownership Summary of Shawn Singh
| Ticker | Comapny | Transaction Date | Type of Owner |
|---|---|---|---|
| VTGN | Vistagen Therapeutics Inc | 2022-08-17 | director & CHIEF EXECUTIVE OFFICER |
| ECTE | Echo Therapeutics Inc | 2009-12-31 | director |
Shawn Singh Latest Holdings Summary
Shawn Singh currently owns a total of 1 stock. Shawn Singh owns 26,008 shares of Vistagen Therapeutics Inc (VTGN) as of August 17, 2022, with a value of $76,203.
Latest Holdings of Shawn Singh
| Ticker | Comapny | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
|---|---|---|---|---|---|
| VTGN | Vistagen Therapeutics Inc | 2022-08-17 | 26,008 | 2.93 | 76,203 |
Holding Weightings of Shawn Singh
Shawn Singh Form 4 Trading Tracker
According to the SEC Form 4 filings, Shawn Singh has made a total of 1 transactions in Vistagen Therapeutics Inc (VTGN) over the past 5 years, including 1 buys and 0 sells. The most-recent trade in Vistagen Therapeutics Inc is the acquisition of 20,000 shares on August 17, 2022, which cost Shawn Singh around $102,000.
Insider Trading History of Shawn Singh
- 1
Shawn Singh Trading Performance
GuruFocus tracks the stock performance after each of Shawn Singh's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by Shawn Singh is -24.55%. GuruFocus also compares Shawn Singh's trading performance to market benchmark return within the same time period. The performance of stocks bought by Shawn Singh within 3 months outperforms 0 times out of 1 transactions in total compared to the return of S&P 500 within the same period.
You can select different timeframes to see how Shawn Singh's insider trading performs compared to the benchmark.
Performance of Shawn Singh
Average Return
Outperforming Transactions
| 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | 3 Years | |
|---|---|---|---|---|---|---|
| Return(%) | -1.09 | | | | | |
| Relative Return to S&P 500(%) | 8.29 | | | | | |
Shawn Singh Ownership Network
Ownership Network List of Shawn Singh
Ownership Network Relation of Shawn Singh
Shawn Singh Owned Company Details
What does Vistagen Therapeutics Inc do?
Who are the key executives at Vistagen Therapeutics Inc?
Shawn Singh is the director & CHIEF EXECUTIVE OFFICER of Vistagen Therapeutics Inc. Other key executives at Vistagen Therapeutics Inc include Chief Operating Officer Joshua S. Prince , CHIEF FINANCIAL OFFICER Cynthia Lynn Anderson , and 10 percent owner Commodore Capital Lp .
Vistagen Therapeutics Inc (VTGN) Insider Trades Summary
Over the past 18 months, Shawn Singh made no insider transaction in Vistagen Therapeutics Inc (VTGN). Other recent insider transactions involving Vistagen Therapeutics Inc (VTGN) include a net purchase of 775,756 shares made by Commodore Capital Lp ,
In summary, during the past 3 months, insiders sold 0 shares of Vistagen Therapeutics Inc (VTGN) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Vistagen Therapeutics Inc (VTGN) were sold and 775,756 shares were bought by its insiders, resulting in a net purchase of 775,756 shares.
Vistagen Therapeutics Inc (VTGN)'s detailed insider trading history can be found in Insider Trading Tracker table.
Vistagen Therapeutics Inc Insider Transactions
Shawn Singh Mailing Address
Above is the net worth, insider trading, and ownership report for Shawn Singh. You might contact Shawn Singh via mailing address: C/o Vistagen Therapeutics, Inc., 343 Allerton Avenue, South San Francisco Ca 94080.
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
